Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 31.09% is 17% above its 5-year average of 26.69%, near the high end of its 5-year range (13.74%–32.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.50% above its 12-month average of 28.92%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
31.09%
OPERATING MARGIN AVG TTM
28.92%
OPERATING MARGIN AVG 3Y
25.87%
OPERATING MARGIN AVG 5Y
26.69%
OPERATING MARGIN AVG 10Y
29.73%
OPERATING MARGIN AVG 15Y
31.00%
OPERATING MARGIN AVG 20Y
30.44%
CURRENT VS TTM AVG
+7.50%
CURRENT VS 3Y AVG
+20.17%
CURRENT VS 5Y AVG
+16.50%
CURRENT VS 10Y AVG
+4.60%
CURRENT VS 15Y AVG
+0.30%
CURRENT VS 20Y AVG
+2.16%
SECTOR MEDIAN · HEALTHCARE
15.73%
median of 85 covered companies
CURRENT VS SECTOR MEDIAN
+97.67%
vs the sector median at left
Roche Holding AG
Market Cap
$359.46B
Operating Margin
31.09%
TTM Avg
28.92%
3Y Avg
25.87%
5Y Avg
26.69%
Market Cap
$358.76B
Operating Margin
4.82%
TTM Avg
6.16%
3Y Avg
7.45%
5Y Avg
7.80%
Market Cap
$369.34B
Operating Margin
36.17%
TTM Avg
33.84%
3Y Avg
25.86%
5Y Avg
23.98%
Market Cap
$455.87B
Operating Margin
29.32%
TTM Avg
24.54%
3Y Avg
25.94%
5Y Avg
26.75%
Market Cap
$255.15B
Operating Margin
22.77%
TTM Avg
20.95%
3Y Avg
17.06%
5Y Avg
15.08%
Market Cap
$234.38B
Operating Margin
17.69%
TTM Avg
18.04%
3Y Avg
18.11%
5Y Avg
20.54%
Market Cap
$205.42B
Operating Margin
43.10%
TTM Avg
42.74%
3Y Avg
42.98%
5Y Avg
42.70%
Market Cap
$193.04B
Operating Margin
17.03%
TTM Avg
17.21%
3Y Avg
17.41%
5Y Avg
17.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | 31.09% | 28.92% | 25.87% | 26.69% |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | 4.82% | 6.16% | 7.45% | 7.80% |
| Merck & Co., Inc. (MRK)vs › | $369.34B | 36.17% | 33.84% | 25.86% | 23.98% |
| AbbVie Inc. (ABBV)vs › | $455.87B | 29.32% | 24.54% | 25.94% | 26.75% |
| AstraZeneca PLC (AZN)vs › | $255.15B | 22.77% | 20.95% | 17.06% | 15.08% |
| Amgen Inc. (AMGN)vs › | $235.85B | 33.18% | 25.38% | 28.78% | 30.08% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | 17.69% | 18.04% | 18.11% | 20.54% |
| Novo Nordisk A/S (NVO)vs › | $205.42B | 43.10% | 42.74% | 42.98% | 42.70% |
| Abbott Laboratories (ABT)vs › | $193.04B | 17.03% | 17.21% | 17.41% | 17.71% |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | 39.74% | 22.76% | 25.11% | 25.54% |
Gross Margin
73.7%
Operating Margin
31.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 31.09% |
| 2025-12-31 | 23.24% |
| 2025-06-30 | 32.43% |
| 2024-12-31 | 13.74% |
| 2024-06-30 | 29.49% |
| 2023-12-31 | 19.37% |
| 2023-06-30 | 31.76% |
| 2022-12-31 | 25.51% |
| 2022-06-30 | 31.80% |
| 2021-12-31 | 25.10% |
| 2021-06-30 | 30.04% |
| 2020-12-31 | 27.14% |
| 2020-06-30 | 33.61% |
| 2019-12-31 | 27.56% |
| 2019-06-30 | 36.53% |
| 2018-12-31 | 28.20% |
| 2018-06-30 | 35.45% |
| 2017-12-31 | 27.64% |
| 2017-06-30 | 34.51% |
| 2016-12-31 | 31.13% |
| 2016-06-30 | 32.91% |
| 2015-12-31 | 28.54% |
| 2015-06-30 | 32.86% |
| 2014-12-31 | 29.72% |
| 2014-06-30 | 36.66% |
| 2013-12-31 | 31.99% |
| 2013-06-30 | 36.35% |
| 2012-12-31 | 33.63% |
| 2012-06-30 | 30.97% |
| 2011-12-31 | 30.97% |
| 2011-06-30 | 32.19% |
| 2010-12-31 | 32.19% |
| 2010-06-30 | 28.52% |
| 2009-12-31 | 28.52% |
| 2009-06-30 | 24.35% |
| 2008-12-31 | 33.65% |
| 2008-06-30 | 27.40% |
| 2007-12-31 | 27.40% |
| 2007-06-30 | 30.15% |
| 2006-12-31 | 28.14% |
| 2006-06-30 | 27.67% |
| 2005-12-31 | 23.61% |
| 2005-06-30 | 25.21% |
| 2004-12-31 | 25.21% |
| 2004-06-30 | 28.73% |
| 2003-12-31 | 21.36% |
| 2003-06-30 | 14.46% |
| 2002-12-31 | 19.70% |
| 2002-06-30 | -10.72% |
| 2001-12-31 | 6.03% |
| 2001-06-30 | 16.24% |
| 2000-12-31 | 11.66% |
| 2000-06-30 | 38.08% |
| 1999-12-31 | 18.78% |
| 1999-06-30 | 27.81% |
| 1998-12-31 | 27.81% |
| 1998-06-30 | 21.72% |
| 1998-01-31 | 21.72% |
